A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies (Q33371505)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies |
scientific article |
Statements
1 reference
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade), in combination with paclitaxel and carboplatin in patients with advanced malignancies (English)
1 reference
Henry C Pitot
1 reference
Alex A Adjei
1 reference
Lorelei J Hanson
1 reference
Charles Erlichman
1 reference
Steven R Alberts
1 reference
Joel M Reid
1 reference
Gary A Croghan
1 reference
Laura Bruzek
1 reference
Aminah Jatoi
1 reference
Angelina D Tan
1 reference
Cynthia Ma
1 reference
Sumithra J Mandrekar
1 reference
John J Wright
1 reference
9 June 2006
1 reference
1 reference
59
1 reference
207-215
1 reference
Identifiers
1 reference
1 reference